Elite Pharmaceuticals, Inc. Financial Ratios — ELTP Stock

Profitability (USD)

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	03/31/2012	03/31/2013	03/31/2014	03/31/2015	03/31/2016	03/31/2017	03/31/2018	03/31/2019	03/31/2020	03/31/2021	03/31/2022	03/31/2023	03/31/2024	03/31/2025	03/31/2026

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	-24.3	- -	- -	- -	43.01	13.15	46.47	-7.77	58.89
Return on Assets (%)	-136.28	13.88	-232.83	20.78	-2.37	11.55	-11.27	-33.57	-9.08	19.9	29.01	9.37	32.29	-4.79	38.24
Return on Capital (%)	- -	- -	- -	- -	- -	18.87	- -	- -	- -	- -	- -	14.97	- -	- -	53.43
Return on Invested Capital (%)	- -	- -	- -	- -	- -	-34.28	- -	- -	- -	- -	- -	11.5	- -	- -	46.91
Gross Margin (%)	58.18	31.98	29.67	39.91	64.12	38.8	52.93	37.89	44.34	46.76	45.86	48.58	46.55	47.7	50.4
EBITDA Margin (%)	-61.14	-33.49	-104.97	-317.53	-61.21	-68.91	-107.99	-104.4	-4.31	14.3	20.16	15.56	21.73	27.75	34.92
Operating Margin (%)	-81.11	-45.93	-114.83	-329.14	-66.54	-76.32	-121.35	-121.01	-12.7	8.29	15.72	11.62	19.05	25.23	33.56
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	59.43	43.1	-58.21	30.35	37.99	44.36
Pretax Margin (%)	-641.15	33.32	-903.07	104.03	-9.63	20.17	-63.27	-131.54	-12.44	16.33	19.54	11.67	0.82	-0.06	38.16
Profit Margin (%)	-621.19	43.72	-896.71	104.09	-5.46	39.54	-49.25	-122.6	-12.45	20.05	27.58	10.43	35.51	-5.13	30.14
Net Income to Common Margin (%)	-621.19	43.72	-2,098.83	576.83	-79.76	254.47	-49.25	-122.6	-12.45	20.05	27.58	10.43	35.51	-5.13	30.14
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	10.64	- -	- -	21.02
Dvd Payout Ratio (%)	- -	- -	57.28	81.95	93.15	84.46	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	-24.3	- -	- -	- -	43.01	13.15	46.47	-7.77	58.89

Credit (USD)

Credit Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	03/31/2012	03/31/2013	03/31/2014	03/31/2015	03/31/2016	03/31/2017	03/31/2018	03/31/2019	03/31/2020	03/31/2021	03/31/2022	03/31/2023	03/31/2024	03/31/2025	03/31/2026

Total Debt	3	4	4	4	3	3	4	4	4	2	3	4	12	11	6
ST Debt	3	4	4	1	1	- -	1	1	2	1	1	- -	5	5	1
LT Debt	- -	- -	- -	3	2	2	3	3	2	2	2	4	7	6	5
Total Debt/EBITDA	-2.29	-3.5	-0.83	-0.23	-0.45	-0.4	-0.49	-0.5	-5.2	0.66	0.43	0.73	0.95	0.47	0.11
Net Debt/EBITDA	-1.84	-3.18	0.6	0.24	1.05	1.2	0.4	-0.22	-3.25	-0.29	-1.04	-0.75	0.04	-0.17	-0.51
Total Debt/EBIT	-1.73	-2.55	-0.76	-0.22	-0.41	-0.36	-0.44	-0.43	-1.76	1.13	0.55	0.98	1.09	0.51	0.12
Net Debt/EBIT	-1.39	-2.32	0.55	0.23	0.97	1.08	0.35	-0.19	-1.1	-0.49	-1.34	-1	0.04	-0.19	-0.54
EBITDA to Interest Expense	-2.27	-2.9	-5.37	-55.44	-27.26	-27.88	-24.01	-21.4	-2.18	13.98	33.91	4.78	20.91	30.2	131.04
EBITDA-CapEx/Interest Expense	-3.29	-3.42	-5.99	-62.4	-34.2	-32.52	-24.83	-21.46	-2.28	12.71	31.32	-0.38	19.53	26.93	128.71
EBIT to Interest Expense	-3.01	-3.98	-5.87	-57.47	-29.63	-30.88	-26.98	-24.81	-6.42	8.11	26.44	3.57	18.33	27.45	125.95
Interest Expense	1	- -	1	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1	- -
Common Equity/Total Assets	-145.31	-77.96	-333.91	-133.99	-104.57	74.8	14.8	-10.28	-13.02	61.67	71.76	70.81	68.83	55.52	71.5
Long-Term Debt/Equity (%)	- -	- -	- -	976.27	19.49	8.42	18.03	- -	18.46	11.02	8.82	12.3	11.67	10.9	4.72
Long-Term Debt/Capital (%)	- -	- -	-0.11	66.42	14.9	7.63	14.83	225.9	13.4	9.6	7.94	10.84	9.69	9.05	4.46
Long-Term Debt/Total Assets (%)	- -	- -	0.36	10.13	6.87	6.3	10.79	13.63	7.88	6.8	6.33	8.71	8.03	6.05	3.38
Total Debt/Equity (%)	-22.68	-46.02	-4.95	1,369.8	30.84	10.32	21.57	-158.72	37.8	14.73	11.03	13.42	20.38	20.4	5.88
Total Debt/Capital (%)	-29.33	-85.25	-5.21	93.2	23.57	9.35	17.75	270.31	27.43	12.84	9.93	11.83	16.93	16.94	5.55
Total Debt/Total Assets (%)	32.96	35.88	16.53	14.21	10.87	7.72	12.91	16.31	16.14	9.08	7.91	9.51	14.03	11.32	4.21
Net Debt to Equity	-18.22	-41.76	3.6	-1,405.88	-72.28	-30.96	-17.28	-67.9	23.66	-6.45	-26.93	-13.67	0.82	-7.54	-27.07
Net Debt/Capital (%)	-22.28	-71.71	3.47	107.66	-260.81	-44.85	-20.9	-211.51	18.6	-6.79	-34.89	-15.83	0.75	-7.6	-35.73
EBITDA	-1	-1	-5	-16	-8	-7	-8	-8	-1	4	7	5	12	23	52
EBITDA-CapEx	-2	-1	-5	-18	-10	-8	-8	-8	-1	3	6	- -	11	21	51
Operating Income (Loss)	-2	-2	-5	-17	-8	-7	-9	-9	-2	2	5	4	11	21	50

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	03/31/2012	03/31/2013	03/31/2014	03/31/2015	03/31/2016	03/31/2017	03/31/2018	03/31/2019	03/31/2020	03/31/2021	03/31/2022	03/31/2023	03/31/2024	03/31/2025	03/31/2026

Cash Ratio	0.15	0.07	1.13	1.47	2.48	3.17	1.4	0.33	0.13	0.55	1.28	1	0.54	0.96	1.71
Current Ratio	0.33	0.47	1.61	2.43	3.6	5.5	2.68	1.28	1.19	2.1	2.82	2.75	3.07	4.88	6.45
Quick Ratio	0.23	0.19	1.25	1.76	2.81	3.45	1.54	0.52	0.61	1.15	1.73	1.39	2.04	3.42	5.15
CFO/Avg Current Liab	-0.09	-0.34	-0.73	-2.69	-0.57	-1.97	-1.14	-1.13	-0.23	0.44	1.04	0.46	-0.31	0.6	1.62
Common Equity/Total Assets	-145.31	-77.96	-333.91	-133.99	-104.57	74.8	14.8	-10.28	-13.02	61.67	71.76	70.81	68.83	55.52	71.5
Long-Term Debt/Equity (%)	- -	- -	- -	976.27	19.49	8.42	18.03	- -	18.46	11.02	8.82	12.3	11.67	10.9	4.72
Long-Term Debt/Capital (%)	- -	- -	-0.11	66.42	14.9	7.63	14.83	225.9	13.4	9.6	7.94	10.84	9.69	9.05	4.46
Long-Term Debt/Total Assets (%)	- -	- -	0.36	10.13	6.87	6.3	10.79	13.63	7.88	6.8	6.33	8.71	8.03	6.05	3.38
Total Debt/Equity (%)	-22.68	-46.02	-4.95	1,369.8	30.84	10.32	21.57	-158.72	37.8	14.73	11.03	13.42	20.38	20.4	5.88
Total Debt/Capital (%)	-29.33	-85.25	-5.21	93.2	23.57	9.35	17.75	270.31	27.43	12.84	9.93	11.83	16.93	16.94	5.55
Total Debt/Total Assets (%)	32.96	35.88	16.53	14.21	10.87	7.72	12.91	16.31	16.14	9.08	7.91	9.51	14.03	11.32	4.21
CFO/Total Liabilities	-1.56	-8.55	-4	-58.88	-13.48	-91.17	-38.76	-25.24	-12.54	31.82	65.56	27.97	-12.41	17.39	60.26
CFO/CapEx	-0.59	-8.28	-7.52	-7.56	-1.42	-7.14	-17.5	-355.08	-51.32	9.68	13.05	0.58	-4	2.95	25.66
Altman's Z-Score	-18.9	-16.82	-16.69	-8.57	-1.47	2.81	-5.25	-11.27	-8.63	-5	-2.51	-2.21	3.33	6.95	8.35

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	03/31/2012	03/31/2013	03/31/2014	03/31/2015	03/31/2016	03/31/2017	03/31/2018	03/31/2019	03/31/2020	03/31/2021	03/31/2022	03/31/2023	03/31/2024	03/31/2025	03/31/2026

Accounts Receivable Turnover	5.01	6.41	6.59	4.6	8.4	7.82	9.27	7.58	6.63	6.68	9.84	11.1	5.02	3.45	3.35
Days Sales Outstanding	72.91	56.95	55.42	79.27	43.47	46.67	39.39	48.17	55.06	54.67	37.08	32.87	72.67	105.67	109.01
Inventory Turnover	2.2	2.78	1.97	1.21	1.42	1.21	0.62	1	2.31	2.95	2.97	2.16	2.69	3.01	3.94
Days Inventory Outstanding	165.86	131.09	185.57	300.64	257.45	300.42	588.07	365.46	157.76	123.64	122.81	169.31	135.55	121.11	92.68
Accounts Payable Turnover	0.26	2.82	2.15	1.47	1.83	6.32	1.47	2.85	6.53	11.47	16.26	10.51	13.04	16.67	17.5
Accounts Payable Turnover Days	1,400.16	129.58	169.55	248.4	199.5	57.75	247.95	128.19	55.89	31.81	22.44	34.74	27.99	21.9	20.85
Cash Conversion Cycle	-1,161.38	58.46	71.45	131.52	101.42	289.34	379.52	285.44	156.93	146.5	137.44	167.44	180.23	204.88	180.84
Inventory to Cash Days	-92.94	-74.15	-130.16	-221.37	-213.98	-253.76	-548.68	-317.29	-102.71	-68.97	-85.74	-136.44	-62.88	-15.45	16.33
Inventories	- -	1	2	3	3	6	5	5	4	5	7	10	13	16	21
Raw Materials	- -	1	2	3	3	6	4	4	3	4	5	5	7	10	13
Work In Process	- -	1	- -	- -	- -	- -	- -	- -	1	1	1	2	2	1	3
Finished Goods	- -	- -	- -	- -	- -	- -	- -	1	- -	- -	- -	2	4	5	5
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	03/31/2012	03/31/2013	03/31/2014	03/31/2015	03/31/2016	03/31/2017	03/31/2018	03/31/2019	03/31/2020	03/31/2021	03/31/2022	03/31/2023	03/31/2024	03/31/2025	03/31/2026

Market Capitalization	30	30	230	158	221	139	80	82	59	61	35	29	166	465	390
- Cash & Cash Equivalents	1	- -	7	7	12	11	7	2	1	3	9	8	7	11	30
+ Preferred Equity and Hybrid Capital	- -	- -	- -	35	44	- -	14	- -	14	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	3	4	4	4	3	3	4	4	4	2	3	4	12	11	6
Enterprise Value	33	34	227	189	257	131	91	84	76	60	30	25	171	464	366
Total Capital	-12	-5	-77	4	15	28	22	1	15	19	28	33	69	64	105
Total Debt/Capital (%)	-29.33	-85.25	-5.21	93.2	23.57	9.35	17.75	270.31	27.43	12.84	9.93	11.83	16.93	16.94	5.55
Total Debt / EV	0.1	0.12	0.02	0.02	0.01	0.02	0.04	0.05	0.05	0.04	0.09	0.15	0.07	0.02	0.02
EV/Sales	13.44	9.86	49.28	37.68	20.54	13.62	12.2	11.12	4.2	2.35	0.92	0.75	3.02	5.52	2.46
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	16.46	4.55	4.79	13.88	19.91	7.05
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	28.38	5.84	6.41	15.84	21.9	7.33
EV/Cash Flow to Firm	135.96	- -	- -	- -	- -	- -	- -	- -	- -	17.01	4.38	5.88	7.65	6.51	15.23
EV/Free Cash Flow to Firm	35.87	- -	- -	- -	- -	- -	- -	- -	- -	15.55	4.08	2.53	7.39	6.28	14.66
Diluted Market Cap	23	42	190	189	209	127	80	82	70	57	35	29	159	465	413
Diluted Enterprise Value	26	46	187	221	245	119	91	83	86	56	30	25	164	464	389
EV per Share	0.1	0.09	0.4	0.3	0.36	0.14	0.11	0.1	0.09	0.06	0.03	0.03	0.16	0.43	0.34
TTM Sales	2	3	5	5	12	10	7	8	18	25	32	34	57	84	149
TTM EBITDA	-1	-1	-5	-16	-8	-7	-8	-8	-1	4	7	5	12	23	52
TTM Operating Income	-2	-2	-5	-17	-8	-7	-9	-9	-2	2	5	4	11	21	50
TTM Cash Flow to Firm	- -	-1	-3	-15	-3	-8	-4	-6	-1	4	7	4	22	71	24
TTM Free Cash Flow to Firm	1	-1	-3	-13	-1	-7	-4	-6	-1	4	7	10	23	74	25

Multiples (USD)

Valuation Multiples API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	03/31/2012	03/31/2013	03/31/2014	03/31/2015	03/31/2016	03/31/2017	03/31/2018	03/31/2019	03/31/2020	03/31/2021	03/31/2022	03/31/2023	03/31/2024	03/31/2025	03/31/2026

Price/Free Cash Flow	84.96	-28.31	-51.92	-14.45	-255.83	-18.69	-17.6	-12.05	-39.53	16.06	5.04	3.24	-65.64	46.56	16.72
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	28.38	5.84	6.41	15.84	21.9	7.33
Enterprise Value	33	34	227	189	257	131	91	84	76	60	30	25	171	464	366
Low Price	0.06	0.05	0.06	0.17	0.2	0.11	0.06	0.07	0.03	0.05	0.02	0.03	0.03	0.12	0.27
EV/Sales	13.44	9.86	49.28	37.68	20.54	13.62	12.2	11.12	4.2	2.35	0.92	0.75	3.02	5.52	2.46
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	16.46	4.55	4.79	13.88	19.91	7.05
Price/Earnings	- -	18.77	- -	5.11	- -	5.13	- -	- -	- -	11.12	3.97	8.25	7.86	- -	8.66
Price/Earnings Average	-1.89	24.98	-0.8	6.37	-18.49	7.08	-26.94	-8.07	-29.79	12.79	5.15	10.48	4.9	-87.76	12.6
Price/Earnings High	-4.47	39.88	-4.65	10.42	-29.74	13.68	-54.18	-11.41	-52.01	18.53	6.81	14.79	10.6	-186.91	19.59
Price/Earnings Low	-1.03	11.73	-0.29	3.47	-13.52	3.76	-13	-6.14	-11.15	9.27	2.27	7.65	1.41	-30.03	6.46
Price/Book Value	-1.99	-3.45	-2.83	-4.54	-6.66	5.42	17.55	-32.89	-18.11	3.75	1.4	1.02	2.89	8.68	3.95
Price/Book Value Average	-2.43	-4.6	-1.15	-5.67	-5.87	7.48	21.82	-30.26	-20.75	4.31	1.82	1.29	1.8	7.08	5.74
Price/Book Value High	-5.75	-7.34	-6.69	-9.27	-9.45	14.46	43.89	-42.76	-36.22	6.25	2.41	1.82	3.9	15.07	8.93
Price/Book Value Low	-1.33	-2.16	-0.41	-3.09	-4.3	3.98	10.53	-23.02	-7.76	3.12	0.8	0.94	0.52	2.42	2.94
Price/Tangible Book Value	-1.91	-3.2	-2.62	-3.84	-5.58	7.23	-25.55	-9.02	-5.95	6.36	1.9	1.3	3.24	9.71	4.15
Price/Tangible Book Value Average	-2.33	-4.26	-1.07	-4.79	-4.92	9.98	-31.76	-8.3	-6.82	7.32	2.47	1.65	2.02	7.91	6.03
Price/Tangible Book Value High	-5.52	-6.79	-6.21	-7.83	-7.92	19.29	-63.87	-11.73	-11.91	10.6	3.26	2.33	4.38	16.85	9.38
Price/Tangible Book Value Low	-1.27	-2	-0.38	-2.61	-3.6	5.3	-15.33	-6.32	-2.55	5.3	1.09	1.21	0.58	2.71	3.09
Price/Sales	9.62	8.21	41.26	29.47	16.72	13.05	10.67	10.76	3.24	2.23	1.09	0.86	2.79	5.53	2.61
Price/Sales Average	11.76	10.92	16.76	36.76	14.75	18.01	13.27	9.9	3.71	2.56	1.42	1.09	1.74	4.51	3.8
Price/Sales High	27.8	17.44	97.61	60.12	23.72	34.81	26.68	13.98	6.48	3.72	1.88	1.54	3.77	9.6	5.91
Price/Sales Low	6.41	5.13	6.04	20.04	10.78	9.57	6.4	7.53	1.39	1.86	0.63	0.8	0.5	1.54	1.95
Price/Cash Flow	-59.19	-16.49	-45.02	-9.79	-75.54	-15.96	-16.55	-11.99	-32.48	17.72	5.43	8.8	-48.84	62.33	16.37
Price/Cash Flow Average	-72.34	-21.95	-18.29	-12.21	-66.65	-22.02	-20.58	-11.03	-37.21	20.37	7.05	11.18	-30.46	50.79	23.82
Price/Cash Flow High	-170.99	-35.04	-106.51	-19.96	-107.22	-42.55	-41.38	-15.58	-64.96	29.53	9.32	15.78	-65.92	108.17	37.02
Price/Cash Flow Low	-39.46	-10.31	-6.59	-6.65	-48.74	-11.7	-9.93	-8.39	-13.92	14.76	3.11	8.16	-8.79	17.38	12.2
Price/Free Cash Flow Average	103.84	-37.69	-21.09	-18.02	-225.7	-25.79	-21.88	-11.09	-45.29	18.47	6.55	4.11	-40.94	37.94	24.32
Price/Free Cash Flow High	245.43	-60.16	-122.83	-29.48	-363.12	-49.83	-44.01	-15.67	-79.06	26.76	8.65	5.8	-88.59	80.8	37.8
Price/Free Cash Flow Low	56.64	-17.69	-7.6	-9.83	-165.05	-13.7	-10.56	-8.44	-16.94	13.38	2.88	3	-11.81	12.98	12.46
EV/Sales Average	16.18	12.78	19.64	45.46	18.47	19.11	14.81	10.25	4.68	2.71	1.24	0.98	1.91	4.5	3.65
EV/Sales High	36.7	19.76	117.45	70.4	27.94	37.69	28.33	14.39	7.47	3.94	1.7	1.43	4.04	9.59	5.77
EV/Sales Low	9.33	6.56	6.67	27.62	14.28	9.77	7.89	7.85	2.33	1.96	0.45	0.68	0.61	1.54	1.79
EV/EBITDA Average	-26.46	-38.16	-18.71	-14.32	-30.17	-27.72	-13.72	-9.82	-108.67	18.97	6.17	6.29	8.8	16.22	10.46
EV/EBITDA High	-60.03	-59.02	-111.89	-22.17	-45.65	-54.69	-26.24	-13.79	-173.54	27.58	8.44	9.18	18.61	34.56	16.52
EV/EBITDA Low	-15.27	-19.6	-6.35	-8.7	-23.33	-14.17	-7.31	-7.52	-54.22	13.68	2.22	4.39	2.81	5.54	5.13
EV/EBIT Average	-19.94	-27.82	-17.11	-13.81	-27.75	-25.03	-12.21	-8.47	-36.84	32.7	7.92	8.42	10.04	17.84	10.89
EV/EBIT High	-45.25	-43.03	-102.28	-21.39	-41.99	-49.38	-23.35	-11.89	-58.83	47.57	10.83	12.29	21.22	38.02	17.19
EV/EBIT Low	-11.51	-14.29	-5.81	-8.39	-21.46	-12.8	-6.5	-6.49	-18.38	23.59	2.85	5.88	3.2	6.09	5.34
Last Price	0.09	0.08	0.41	0.25	0.31	0.15	0.1	0.1	0.07	0.06	0.03	0.03	0.16	0.44	0.36
High Price	0.26	0.17	0.97	0.51	0.44	0.4	0.25	0.13	0.14	0.1	0.06	0.05	0.21	0.75	0.82
Enterprise Value Average	39	43	90	228	231	184	110	78	84	69	40	33	108	378	544
Enterprise Value High	89	67	540	353	349	363	211	109	134	100	55	49	229	806	859
Enterprise Value Low	23	22	31	138	179	94	59	59	42	50	14	23	35	129	267

Shares Outstanding	332	374	560	631	711	928	803	825	840	1,009	1,011	1,014	1,068	1,068	1,077
Diluted Weighted Avg Shares	259	527	463	758	674	845	798	816	993	943	1,011	1,013	1,023	1,068	1,138
Basic Weighted Avg Shares	259	349	463	591	674	839	796	814	832	943	1,011	1,013	1,015	1,068	1,073
Revenue per Share	0.01	0.01	0.01	0.01	0.02	0.01	0.01	0.01	0.02	0.03	0.03	0.03	0.06	0.08	0.14
EBITDA per Share	-0.01	- -	-0.01	-0.03	-0.01	-0.01	-0.01	-0.01	- -	- -	0.01	0.01	0.01	0.02	0.05
Operating Income per Share	-0.01	- -	-0.01	-0.03	-0.01	-0.01	-0.01	-0.01	- -	- -	0.01	- -	0.01	0.02	0.05
Basic EPS, GAAP	-0.06	- -	-0.21	0.05	-0.01	0.03	- -	-0.01	- -	0.01	0.01	- -	0.02	- -	0.04
Basic EPS from Cont Ops	-0.06	- -	-0.09	0.01	- -	- -	- -	-0.01	- -	0.01	0.01	- -	0.02	- -	0.04
Diluted EPS, GAAP	-0.06	- -	-0.21	0.04	-0.01	0.03	- -	-0.01	- -	0.01	0.01	- -	0.02	- -	0.04
Diluted EPS from Cont Ops	-0.06	- -	-0.09	0.01	- -	- -	- -	-0.01	- -	0.01	0.01	- -	0.02	- -	0.04
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	- -	- -	-0.01	-0.03	- -	-0.01	-0.01	-0.01	- -	- -	0.01	- -	- -	0.01	0.02
Free Cash Flow per Basic Share	- -	-0.01	-0.01	-0.03	-0.01	-0.01	-0.01	-0.01	- -	- -	0.01	- -	- -	- -	0.02
Cash & Equivalents per Share	- -	- -	0.01	0.01	0.02	0.01	0.01	- -	- -	- -	0.01	0.01	0.01	0.01	0.03
Book Value per Share	-0.05	-0.02	-0.14	-0.06	-0.05	0.03	0.01	- -	- -	0.02	0.02	0.03	0.05	0.05	0.09
Tangible Book Value per Share	-0.05	-0.03	-0.16	-0.07	-0.06	0.02	- -	-0.01	-0.01	0.01	0.02	0.02	0.05	0.04	0.09

Elite Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)